Dev

A recent Cochrane Review update was published to assess the clinical efficacy and safety of statins in treating Alzheimer’s Disease and Vascular Dementia. “Statins for the treatment of dementia” is an update of a Cochrane Review originally published in 2010. …

A recent paper addresses the challenges and explores opportunities to stimulate repurposing of FDA-approved drugs for Alzheimer’s, Parkinson’s and related diseases. A new peer-reviewed publication from the Alzheimer’s Drug Discovery Foundation (ADDF) and The Michael J. Fox Foundation for Parkinson’s…

The first follow-up conference to last December’s G8 Summit on Dementia took place recently in London to encourage leading nations to follow the commitments made in 2013. The Global Dementia Legacy Event on Finance and Social Investment was held in…

A new study suggests there could be a way to harness the brain’s capacity to self-repair and make new brain cells and perhaps preserve brain function in neurodegenerative diseases. In Alzheimer’s, Parkinson’s, variant Creutzfeldt-Jakob and other brain-wasting prion diseases, cells…

A new report from Alzheimer’s Research UK, featuring analysis from Office of Health Economics (OHE), has modelled the impact of new treatments for dementia were they to be introduced in the UK from 2020. The report entitled "Defeat Dementia: The…

Writing in the June 12 PLOS Pathogens, researchers led by Olivier Andréoletti at the National Veterinary School of Toulouse, France, report a technique to detect tiny amounts of toxic prions in blood. The researchers hope such a test will be…